These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 35230260)
1. Controversies about the systematic preoperative pharmacological treatment before pheochromocytoma or paraganglioma surgery. Castinetti F; De Freminville JB; Guerin C; Cornu E; Sarlon G; Amar L Eur J Endocrinol; 2022 Mar; 186(5):D17-D24. PubMed ID: 35230260 [TBL] [Abstract][Full Text] [Related]
2. Non-Selective Alpha-Blockers Provide More Stable Intraoperative Hemodynamic Control Compared with Selective Alpha1-Blockers in Patients with Pheochromocytoma and Paraganglioma: A Single-Center Retrospective Cohort Study with a Propensity Score-Matched Analysis from China. Yang Y; Zhang J; Fang L; Jia X; Zhang W Drug Des Devel Ther; 2022; 16():3599-3608. PubMed ID: 36262769 [TBL] [Abstract][Full Text] [Related]
3. Influence of duration of preoperative treatment with phenoxybenzamine and secretory phenotypes on perioperative hemodynamics and postoperative outcomes in pheochromocytoma and paraganglioma. Yao Y; Guo Y; Fan J; Lin T; Wang L; Zhang S Front Endocrinol (Lausanne); 2023; 14():1139015. PubMed ID: 37152936 [TBL] [Abstract][Full Text] [Related]
4. Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma. Berends AMA; Kerstens MN; Lenders JWM; Timmers HJLM J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32726444 [TBL] [Abstract][Full Text] [Related]
5. Preoperative Management of Pheochromocytoma and Paraganglioma. Fang F; Ding L; He Q; Liu M Front Endocrinol (Lausanne); 2020; 11():586795. PubMed ID: 33117294 [TBL] [Abstract][Full Text] [Related]
6. The role of pre-operative α-blockade in patients with normotensive phaeochromocytoma or paraganglioma: A retrospective cohort study. Kong H; Li N; Li XY; Wang DX Eur J Anaesthesiol; 2018 Nov; 35(11):898-899. PubMed ID: 30278035 [No Abstract] [Full Text] [Related]
8. Preoperative alpha-blockade in phaeochromocytoma and paraganglioma: is it always necessary? Isaacs M; Lee P Clin Endocrinol (Oxf); 2017 Mar; 86(3):309-314. PubMed ID: 27864838 [TBL] [Abstract][Full Text] [Related]
9. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma. Gruber LM; Jasim S; Ducharme-Smith A; Weingarten T; Young WF; Bancos I J Clin Endocrinol Metab; 2021 May; 106(6):e2393-e2401. PubMed ID: 33693908 [TBL] [Abstract][Full Text] [Related]
10. Preoperative α-blockade versus no blockade for pheochromocytoma-paraganglioma patients undergoing surgery: a systematic review and updated meta-analysis. Wang J; Liu Q; Jiang S; Zhang J; He J; Li Y; Wang D Int J Surg; 2023 May; 109(5):1470-1480. PubMed ID: 37037514 [TBL] [Abstract][Full Text] [Related]
11. To block, or not to block … is it still the question? Effectiveness of alpha- and beta-blockade in phaeochromocytoma surgery: an institutional analysis. Van Den Heede K; Paspala A; Chander N; Chidambaram S; Wernig F; Todd JF; DiMarco AN; Palazzo FF Ann R Coll Surg Engl; 2022 Feb; 104(2):138-143. PubMed ID: 34582296 [TBL] [Abstract][Full Text] [Related]
12. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines]. Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788 [TBL] [Abstract][Full Text] [Related]
13. Pheochromocytoma and Paraganglioma in Pregnancy: a New Era. Gruber LM; Young WF; Bancos I Curr Cardiol Rep; 2021 May; 23(6):60. PubMed ID: 33961120 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients. Kim JH; Lee HC; Kim SJ; Lee KE; Jung KC Front Endocrinol (Lausanne); 2022; 13():816833. PubMed ID: 35282440 [TBL] [Abstract][Full Text] [Related]
15. Perioperative hemodynamic instability in pheochromocytoma and sympathetic paraganglioma patients. Kim JH; Lee HC; Kim SJ; Yoon SB; Kong SH; Yu HW; Chai YJ; Choi JY; Lee KE; Lee KW; Min SK; Shin CS; Park KJ Sci Rep; 2021 Sep; 11(1):18574. PubMed ID: 34535733 [TBL] [Abstract][Full Text] [Related]
16. Preoperative pharmacological management of phaeochromocytoma. van der Horst-Schrivers AN; Kerstens MN; Wolffenbuttel BH Neth J Med; 2006 Sep; 64(8):290-5. PubMed ID: 16990692 [TBL] [Abstract][Full Text] [Related]
17. Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatment. Januszewicz M; Dobrowolski P; Januszewicz A; Warchoł-Celińska E; Jóźwik-Plebanek K; Motyl D; Kabat M; Pęczkowska M; Michałowska I; Ambroziak U; Toutounchi S; Gałązka Z; Courcelles L; Pappaccogli M; Eisenhofer G; Persu A; Lenders JWM; Kądziela J; Prejbisz A Blood Press; 2021 Jun; 30(3):172-179. PubMed ID: 33586556 [TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma crisis is not a surgical emergency. Scholten A; Cisco RM; Vriens MR; Cohen JK; Mitmaker EJ; Liu C; Tyrrell JB; Shen WT; Duh QY J Clin Endocrinol Metab; 2013 Feb; 98(2):581-91. PubMed ID: 23284003 [TBL] [Abstract][Full Text] [Related]
19. Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary? Shao Y; Chen R; Shen ZJ; Teng Y; Huang P; Rui WB; Xie X; Zhou WL J Hypertens; 2011 Dec; 29(12):2429-32. PubMed ID: 22025238 [TBL] [Abstract][Full Text] [Related]
20. Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma. Lopez C; Bima C; Bollati M; Bioletto F; Procopio M; Arata S; Candela DG; Beccuti G; Ghigo E; Maccario M; Parasiliti-Caprino M Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]